Medical Xpress May 16, 2022
University of Sheffield

A new study, published in JAMA, has found that robotic surgery reduces the chance of readmission by half (52 percent), and revealed a “striking” four-fold (77 percent) reduction in prevalence of blood clots (deep vein thrombus and pulmonary emboli)—a significant cause of health decline and morbidity—when compared to patients who had open surgery.

Patients’ —assessed by daily steps tracked on a wearable smart sensor—stamina and also increased.

Researchers say the findings provide the strongest evidence so far of the patient benefit of robot-assisted and are now urging National Institute of Clinical Excellence (NICE) to make it available as a clinical option across the UK for all major abdominal surgeries including colorectal, gastro-intestinal, and gynecological.


Today's Sponsors

Crossover Health

Today's Sponsors

Health Edge

Today's Sponsor


Topics: Patient / Consumer, Provider, Robotics/RPA, Technology
10 biggest ASC deals in Q2
Multispecialty ASCs comprise 66.2% of surgery center market share: 5 notes
Virtual Platforms For Surgery Are Gaining Traction
USPI striding ahead of competition in total ASCs, physicians
5 factors that will make or break ASCs